Lisa Teot

Lisa Teot, MD

Director, Cytopathology; Director, Fellowship Program; Staff Pathologist

Lecturer of Pathology; Harvard Medical School

    Contact: 617-355-7431
  • Fax: 617-730-0207

Medical Services

Specialties

  • Sarcoma
  • Bone Tumors
  • Pathology
  • Cytopathology

Departments

  • Pathology

Languages

  • English
To schedule an appointment: Call 617-355-7431

Experience and Education

Education

Undergraduate Degree, BA Biology

Williams College, 1982

Williamstown, MA

Medical School

George Washington University, 1986

Washington, DC

Internship

George Washington University Medical Center, 1986-1988

Washington, DC

Residency, Anatomic and Clinical Pathology

George Washington University Medical Center, Washington, DC; North Carolina Baptist Hospital, Bowman Gray School of Medicine, Winston-Salem, NC, 1988-1991

Certifications

  • Anatomic and Clinical Pathology, Cytopathology

Research


Publications

Publications powered by Harvard Catalyst Profiles
  1. Strickland KC, Vivero M, Jo VY, Lowe AC, Hollowell M, Qian X, Wieczorek TJ, French CA, Teot LA, Sadow PM, Alexander EK, Cibas ES, Barletta JA, Krane JF. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis. Thyroid. 2016 Oct; 26(10):1466-1471.
  2. Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 Oct; 63(10):1737-43.
  3. Morris CD, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG, Randall RL. Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group. J Surg Oncol. 2016 Mar; 113(4):351-4.
  4. Arnold MA, Anderson JR, Gastier-Foster JM, Barr FG, Skapek SX, Hawkins DS, Raney RB, Parham DM, Teot LA, Rudzinski ER, Walterhouse DO. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Apr; 63(4):634-9.
  5. Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61.
  6. Calderwood L, Holm IA, Teot LA, Anselm I. Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature. J Child Neurol. 2016 Feb; 31(2):190-4.
  7. Rudzinski ER, Anderson JR, Hawkins DS, Skapek SX, Parham DM, Teot LA. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Arch Pathol Lab Med. 2015 Oct; 139(10):1281-7.
  8. Shillingford NM, Calicchio ML, Teot LA, Boyd T, Kurek KC, Goldsmith JD, Bousvaros A, Perez-Atayde AR, Kozakewich HP. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50.
  9. Pluchinotta FR, Porayette P, Zaidi AH, Baci J, Teot L, Sanders SP, Prabhu SP. Postmortem imaging in congenital heart disease: preliminary experience. Acta Radiol. 2015 Oct; 56(10):1264-72.
  10. Wu P, Teot L, Murdoch G, Monaghan-Nichols AP, McFadden K. Neuropathology of 22q11 deletion syndrome in an infant. Pediatr Dev Pathol. 2014 Sep-Oct; 17(5):386-92.
  11. Show all
  12. Zsengellér ZK, Aljinovic N, Teot LA, Korson M, Rodig N, Sloan JL, Venditti CP, Berry GT, Rosen S. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. Pediatr Nephrol. 2014 Nov; 29(11):2139-46.
  13. Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA, Parham DM. Myogenin, AP2ß, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol. 2014 May; 38(5):654-9.
  14. Monaco SE, Teot LA. Cytopathology of pediatric malignancies: where are we today with fine-needle aspiration biopsies in pediatric oncology? Cancer Cytopathol. 2014 May; 122(5):322-36.
  15. Heidary G, Calderwood L, Cox GF, Robson CD, Teot LA, Mullon J, Anselm I. Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. J Neuroophthalmol. 2014 Mar; 34(1):39-43.
  16. Hartman RJ, Welchons DR, Teot L, Chow J, Cendron M. Incidental capture of rarely diagnosed pediatric tumor: an infant boy with clear cell sarcoma of the kidney. Urology. 2013 Dec; 82(6):1416-8.
  17. Pluchinotta FR, Porayette P, Myers PO, Chen P, Feins E, Teot L, Prabhu SP, Sanders SP. Postmortem imaging of antemortem myocardial ischaemia. Eur Radiol. 2014 Jan; 24(1):34-41.
  18. Hodges HK, Lee PY, Hausmann JS, Teot LA, Sanford EL, Levin KW. Hypercalcemia and miliary sarcoidosis in a 15-year-old boy. Arthritis Rheum. 2013 Aug; 65(8):2112.
  19. Colello SS, Cunningham MJ, Robson CD, Teot LA. Radiology quiz case 1. Diagnosis: congenital cervical teratoma. JAMA Otolaryngol Head Neck Surg. 2013 Jun; 139(6):643-5.
  20. Raney B, Huh W, Hawkins D, Hayes-Jordan A, Million L, Rodeberg D, Teot L, Anderson J. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2013 Mar; 60(3):371-6.
  21. Beroukhim RS, del Nido P, Teot LA, Janeway K, Geva T. Cardiac paraganglioma in an adolescent. Circulation. 2012 Feb 7; 125(5):e322-4.
  22. Monaco SE, Wu Y, Teot LA, Cai G. Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas. Diagn Cytopathol. 2013 Apr; 41(4):308-15.
  23. Ajose-Popoola O, Lin HW, Silvera VM, Teot LA, Madsen JR, Meara JG, Rahbar R. Nasal glioma: prenatal diagnosis and multidisciplinary surgical approach. Skull Base Rep. 2011 Nov; 1(2):83-8.
  24. Cai G, Teot LA, Khalbuss WE, Yu J, Monaco SE, Jukic DM, Parwani AV. Cytologic evaluation of image-guided fine needle aspiration biopsies via robotic microscopy: A validation study. J Pathol Inform. 2010; 1.
  25. Khalbuss WE, Teot LA, Monaco SE. Diagnostic accuracy and limitations of fine-needle aspiration cytology of bone and soft tissue lesions: a review of 1114 cases with cytological-histological correlation. Cancer Cytopathol. 2010 Feb 25; 118(1):24-32.
  26. Monaco SE, Teot LA, Felgar RE, Surti U, Cai G. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer. 2009 Oct 25; 117(5):338-48.
  27. Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, Parham DM, Teot LA, Wharam MD, Breneman JC, Donaldson SS, Anderson JR, Meyer WH. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol. 2009 Nov 1; 27(31):5182-8.
  28. Meaume S, Kerihuel JC, Constans T, Teot L, Lerebours E, Kern J, Bourdel Marchasson I. Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial. J Nutr Health Aging. 2009 Aug; 13(7):623-30.
  29. Anne S, Teot LA, Mandell DL. Fine needle aspiration biopsy: role in diagnosis of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol. 2008 Oct; 72(10):1547-53.
  30. Nayak JV, Teot LA, Vyas Y, Snyderman CH, Toh EH, Deleyiannis FW. Head and neck epithelioid sarcoma in a child: diagnostic dilemma and anterolateral thigh free flap reconstruction. Int J Pediatr Otorhinolaryngol. 2008 May; 72(5):719-24.
  31. Rund CR, Moser AJ, Lee KK, Zeh HJ, Teot LA, Dacic S, Krasinskas AM. Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas. Mod Pathol. 2008 May; 21(5):559-64.
  32. Cai G, Khalbuss WE, Yu J, Parwani AV, Jukic D, Teot LA. Cytological evaluation of image-guided fine needle aspiration biopsies via robotic microscopy: a pilot validation study. 2008.
  33. Monaco SE, Sherer M, Teot LA, Cai G. Fluorescence in-situ hybridization (FISH) studies on direct smears: an approach to enhance the fine needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. 2008.
  34. Cai G, Monacro SE, Teot LA. Assessment of estrogen receptor (ER), progesterone receptor (PR) and Her2/neu status in fine needle aspirates of metastatic breast carcinomas. 2008.
  35. Cai G, Khalbuss WE, Teot LA. Diagnostic values of endobronchial ultrasound-guided fine needle aspiration biopsy (EBUS-FNAB) in assessment of mediastinal lymphdenopathy. 2008.
  36. LaCaria TM, Teot LA, Cai G. Utility of glypican-3, alpha-fetroprotein, and HepPar-1 as a panel for detecting hepatocellular carcinomas in fine needle aspiration biopsies. 2008.
  37. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, Ladanyi M. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007 Dec; 46(12):1051-60.
  38. Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. J Clin Oncol. 2007 May 20; 25(15):2057-62.
  39. Teot LA, Sposto R, Khayat A, Qualman S, Reaman G, Parham D. The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group. Pediatr Dev Pathol. 2007 May-Jun; 10(3):199-207.
  40. Nicol K, Savell V, Moore J, Teot L, Spunt SL, Qualman S. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study. Pediatr Dev Pathol. 2007 Mar-Apr; 10(2):89-97.
  41. Morotti RA, Nicol KK, Parham DM, Teot LA, Moore J, Hayes J, Meyer W, Qualman SJ. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am J Surg Pathol. 2006 Aug; 30(8):962-8.
  42. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 2006 Jun; 86(6):547-56.
  43. Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing's sarcoma family of tumors: current management. Oncologist. 2006 May; 11(5):503-19.
  44. Bernstein M, Kovar H, Paulssen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. Principles and Practice of Pediatric Oncology. Pizzo PA, Polick DG. 2006; 1002-1032.
  45. Teot LA. ASCP Check Sample: Cytopathology Number C-10 2006. FNA of masses arising at the angle of the jaw in pediatric patients. 2006.
  46. Messing EM, Teot L, Korman H, Underhill E, Barker E, Stork B, Qian J, Bostwick DG. Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States. J Urol. 2005 Oct; 174(4 Pt 1):1238-41.
  47. Santos RG, Alissa F, Reyes J, Teot L, Ameen N. Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation. Pediatr Transplant. 2005 Feb; 9(1):112-6.
  48. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol. 2005 Jan-Feb; 8(1):141.
  49. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol. 2004 Nov-Dec; 7(6):583-94.
  50. Wharam MD, Meza J, Anderson J, Breneman JC, Donaldson SS, Fitzgerald TJ, Michalski J, Teot LA, Wiener ES, Meyer WH. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 2004 May 15; 22(10):1902-8.
  51. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9(4):422-41.
  52. Kearns MB, Teot LA. Tech Sample: Cytotechnology Number CY-5 2004. Small round cell sarcomas: Cytologic diagnosis of alveolar rhabdomyosarcoma and extraosseous Ewing sarcoma. 2004.
  53. Gorlick RG, Toretsky JA, Marina N, Wolden SL, Randal RL, Gebhardt MC, Teot LA, Bernstein M. Bone Tumors. Cancer Medicine-6. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Jr, Gansler TS, Holland JF, Frei E III. 2003; 2383-2403.
  54. Pateder DB, Gish MW, O'Keefe RJ, Hicks DG, Teot LA, Rosier RN. Parathyroid hormone-related Peptide expression in cartilaginous tumors. Clin Orthop Relat Res. 2002 Oct; (403):198-204.
  55. Lewis WB, Patel U, Roberts JK, Palis J, Teot L. Angiocentric T-cell lymphoma of the temporal bone. Otolaryngol Head Neck Surg. 2002 Jan; 126(1):85-6.
  56. Smith LM, Anderson JR, Qualman SJ, Crist WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. J Clin Oncol. 2001 Oct 15; 19(20):4058-64.
  57. Faure P, Canovas F, Bonnel F, Teot L, Quatra F, Giovannini UM, Colonna MR. Free osteocutaneous scapular apophysis flap for reconstruction of the lateral malleolus. Ann Plast Surg. 2001 Sep; 47(3):328-31.
  58. Spunt SL, Anderson JR, Teot LA, Breneman JC, Meyer WH, Pappo AS. Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside of the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer. 2001 Jul 1; 92(1):121-5.
  59. Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol. 2001 May; 23(4):225-33.
  60. Pappo AS, Lyden E, Breneman J, Wiener E, Teot L, Meza J, Crist W, Vietti T. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study. J Clin Oncol. 2001 Jan 1; 19(1):213-9.
  61. Schwartz CL, Bernstein M, Teot L, Devidas M, Link M. Cyclosporin A (CSA) to overcome multiple drug resistance in osteogenic sarcoma (OS): A Pediatric Oncology Group study (POG 9351). Med Pediatr Oncol. 2001; 37:177.
  62. LaPoint SF, Powers JM, Woodruff JM, MacCollin M, Jacoby LB, Vortmeyer AO, Zhuang Z, Fong CT, Ifthikharuddin SF, Teot L, Coniglio JU, Sullivan RP. Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia? Acta Neuropathol. 2000 Jan; 99(1):67-72.
  63. Morotti R, Hammond S, Parham D, Teot L, Crist W, Qualman S. Myogenin is the primary immunostain to identify rhabdomyosarcoma (RMS) versus other malignant or reactive lesions. Mod Pathol. 2000; 13:2P.
  64. Nicol K, Parham D, Teot L, Qualman S. Undifferentiated embryonal sarcoma of the liver (UESL) is not biliary tree rhabdomyosarcoma (BTRMS). Mod Pathol. 2000; 13:4P.
  65. Teot L, Giovannini UM, Colonna MR. Use of free scapular crest flap in pediatric epiphyseal reconstructive procedures. Clin Orthop Relat Res. 1999 Aug; (365):211-20.
  66. Kearns MB, Teot LA. Tech Sample: Cytotechnology Number CY-5 1999. Giant cell lesions of bone: An integrated approach to diagnosis. 1999.
  67. Grimsrud CD, Bauhauer JF, Teot L, O'Keefe R. Orthopedic short stories: Lytic lesion of the talus. American Academy of Orthopedic Surgeons (on-line). 1999.
  68. Geisinger KR, Sheppard EA, Teot LA, Raab SS. Histopathologic practices for esophageal biopsy specimens: survey results and implications for surveillance in patients with Barrett's esophagus. Am J Clin Pathol. 1998 Aug; 110(2):219-23.
  69. O'Keefe RJ, Rosier RN, Teot LA, Stewart JM, Hicks DG. Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction. Iowa Orthop J. 1998; 18:26-34.
  70. Rosier RN, Hicks DG, Teot LA, Puzas JE, O'Keefe RJ. Mechanisms of bone metastasis. Assessment and Treatment of Cancer Pain: Progress in Pain Research and Management. Payne R, Patt R, Hill CS. 1998; 12.
  71. Teot LA, Geisinger KR. Fine needle aspiration of the liver and pancreas. Atlas of Difficult Diagnoses in Cytopathology. Atkinson BF, Silverman JF. 1998; 327-349.
  72. Zotalis G, Lewis GD, Teot LA, Hicks DG, Hsu J, O'Keefe RJ, Rosier RN, Messing EM, Puzas JE. In vitro characterization of interactions of prostate cancer cell lins with bone: A potential model for bone metastasis. Lab Invest. 1998; 78:166A.
  73. Wang AR, Zotalis G, Teot LA, O'Keefe RJ, McGary CT, Rosier RN, Hicks DG. Dedifferentiated chondrosarcoma: An immunohistochemical study. Lab Invest. 1998; 78:16A.
  74. Rosier RN, O'Keefe RJ, Teot LA, Fox EJ, Nester TA, Puzas JE, Reynolds PR, Hicks DG. P-glycoprotein expression in cartilaginous tumors. J Surg Oncol. 1997 Jun; 65(2):95-105.
  75. O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest. 1997 Apr; 76(4):457-65.
  76. Powers CN, Frable WJ. Review of: Fine Needle Aspiration Biopsy of the Head and Neck. Am J Clin Pathol. 1997; 107:617-618.
  77. Ayala AG, Ro JY, Teot LA, Spjut HJ. Neoplasms and tumor-like lesions of bone. Principles and Practice of Surgical Pathology and Cytopathology. Silverberg SG, DeLellis RA, Frable WJ. 1997; 863-941.
  78. Vernooy RA, Hicks DG, O'Keefe RJ, Grimsrud C, Teot LA. Heterotopic ossification in sigmoid colon carcinoma: Expression of osteoinductive factors by tumor cells may explain stromal bone formation. Lab Invest. 1997; 76:154A.
  79. Kilpatrick SE, Teot LA, Stanley MW, Ward WG, Savage PD, Geisinger KR. Fine-needle aspiration biopsy of synovial sarcoma. A cytomorphologic analysis of primary, recurrent, and metastatic tumors. Am J Clin Pathol. 1996 Dec; 106(6):769-75.
  80. Teot LA, Sexton CW. Mollaret's meningitis: case report with immunocytochemical and polymerase chain reaction amplification studies. Diagn Cytopathol. 1996 Nov; 15(4):345-8.
  81. Teot LA, O'Keefe RJ, Rosier RN, O'Connell JX, Fox EJ, Hicks DG. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol. 1996 Jul; 27(7):625-32.
  82. Silverman JF, Baird DB, Teot LA, Cappellari JO, Geisinger KR. Fine-needle aspiration cytology of metastatic small cell carcinoma of the colon: a report of three cases. Diagn Cytopathol. 1996 Jul; 15(1):54-9.
  83. Teot LA, Hicks DG, O'Keefe RJ, Rosier RN. Cytokine expression in Ewing's sarcoma/primitive neuroectodermal tumor: A possible mechanism mediating osteoclastic activity and bone destruction. Trans Orthop. Res. Soc. 1996; 21:182A.
  84. Chouairy C, Teot LA, Rosier RN, O'Keefe RJ, Hicks DG. Cytokine expression in Langerhans cell histiocytosis of bone: an immunohistochemical study. Mod Pathol. 1996; 9:5A.
  85. Teot LA, Kilpatrick SE, Hicks DG, O'Keefe RJ. Myositis ossificans: Variations in fine needle aspiration biopsy cytology correlate with lesional maturation. Acta Cytol. 1996; 40:1089.
  86. Steward JMM, Teot LA, O'Keefe RJ, Rosier RN, Hicks DG. Localization of cytokines and matrix metalloproteinase production in pigmented villonodular synovitis. Mod Pathol. 1996; 9:14A.
  87. Saunders C, Teot LA, DelSignore JL, Rosier RN, Dvoretsky PM, Hicks DG. Mast cell disease presenting as a solitary skeletal lesion: a report of three cases. Mod Pathol. 1996; 9:13A.
  88. Katzman P, Hicks DG, Geisinger KR, Rosier RN, Teot LA. Immunohistochemical detection of P-glycoprotein in rhabdomyosarcoma: correlation with patient outcome. Mod Pathol. 1996; 9:8A.
  89. Kilpatrick SE, Teot LA, Stanley MW, Ward WG, Savage PD, Geisinger KR. Fine needle aspiration biopsy of synovial sarcoma: A cytomorphologic analysis of primary, recurrent, and metastic tumors. Acta Cytol. 1996; 40:1089.
  90. O'Keefe RJ, Hicks DG, Police P, Teot LA, Puzas JE, Rosier RN. Cytokine and growth factor expression in carcinomas with skeletal metastasis. J Bone Min Res. 1996; 11(supplement 1):S360A.
  91. Rosier RN, Teot LA, Hicks DG, Schwartz C, O'Keefe RJ, Puzas JE. Multiple drug resistance in osteosarcoma. Iowa Orthop J. 1995; 15:66-73.
  92. O'Keefe RJ, Teot LA, Singh D, Rosier RN, Puzas JE, Hicks DG. Expression of resorption stimulating cytokines by osteoclasts: Evidence for autocrine/paracrine regulation. J Bone Min Res. 1995; 10(supplement 1):M332A.
  93. Teot LA, Geisinger KR. Diagnostic esophageal cytology and its histopathologic basis. The Esophagus. Castell DO. 1995; 179-204.
  94. Teot LA, Geisinger KR, Lantz PE. Segmental agenesis of small intestional muscularis propria. 1995.
  95. Sheffeld MV, Teot LA. Fine needle aspiration biopsy of bone lesions: clinical radiographic and histologic correleations. Mod Pathol. 1995; 8:240A.
  96. Willis J, Hicks DG, Teot LA, Rosier RN, Abdul-Karim FW, Puzas JE. Immunocytochemical localization of lysosomal enzymes in skeletal disorders with abnormal bone remodeling. Mod Pathol. 1995; 8:240A.
  97. Kilpatrick SE, Teot LA, Geisinger KR, Martin PL, Shumate DK, Zbieranski N, Russell GB, Fletcher CD. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis. Cancer. 1994 Dec 15; 74(12):3227-33.
  98. Teot L, Bosse JP. The use of scapular skin island flaps in the treatment of axillary postburn scar contractures. Br J Plast Surg. 1994 Mar; 47(2):108-11.
  99. Sexton CW, Teot LA. Further investigation of Mollaret's cells. Acta Cytol. 1994; 38:875.
  100. Silverman JF, Baird DB, Teot LA, Capperllari JO, Geisinger KR. Fine needle aspiration cytology of metastatic small cell carcinoma of the colon: A report of three cases with ancillary studies. Acta Cytol. 1994; 38:836.
  101. Prahlow JA, Teot LA. Histiocytoid cardiomyopathy: case report and literature review. J Forensic Sci. 1993 Nov; 38(6):1427-35.
  102. Greig PC, Ernest JM, Teot L, Erikson M, Talley R. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol. 1993 Oct; 169(4):1035-44.
  103. Pettenati MJ, Teot LA, Smith C, Hayworth R, Thomas IT, Veille JC, Rao PN. Unbalanced mosaic karyotypes with different structural abnormalities involving a common chromosome region: report of two cases. Am J Med Genet. 1993 Feb 1; 45(3):365-9.
  104. Teot LA, Geisinger KR. Diagnostic esophageal cytology: An overview. Cytopathology Annual. Schmidt WA, Miller TR. 1993; 89-114.
  105. Geisinger KR, Teot LA. Positive tests for cytomegalovirus in AIDS patients (letter). Am J Gastroenterol. 1993; 88:1800-1801.
  106. Klaus J. Lewin, Robert H. Riddell, Wilfred M. Weinstein. Review of: Gastrointestinal Pathology and Its Clinical Implications Vol 2. JAMA. 1993; 269:2147-2148.
  107. Teot L, Souyris F, Bosse JP. Pedicle scapular apophysis transplantation in congenital limb malformations. Ann Plast Surg. 1992 Oct; 29(4):332-40.
  108. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer. 1992 Jan 1; 69(1):8-16.
  109. Teot LA, Geisinger KR. Diagnostic esophageal cytology and its histopathologic basis. The Esophagus. Castell DO. 1992; 187-216.
  110. Thompson EN III, Teot LA, Geisinger KR. Exfoliative and aspiration cytomorphology of intraabdominal desmoplastic small round cell tumor: the first reported case. Acta Cytol. 1992; 599.
  111. Klaus J. Lewin, Robert H. Riddell, Wilfred M. Weinstein. Review of: Gastrointestinal Pathology and Its Clinical Implications Vols 1. JAMA. 1992; 269:2147-2148.
  112. Geisinger KR, Teot LA, Richter JR. A comparative cytopathologic and histologic study of aypia, dysplasia and adenocarcinoma in Barrett's esophagus. Cancer. 1992; 69(1):8-16.
  113. Teot LA, Accettullo L, Geisinger KR. Barrett's esophagus: The complementarity of endoscopic cytologic brushings and biopsies and DMA ploidy by image analysis. Acta Cytol. 1992; 36:624.
  114. Teot LA, Ducatman BS, Geisinger KR. Cytologic diagnosis of cytomegaloviral esophagitis: A report of three acquired immunodeficiency syndrome-related cases. Acta Cytol. 1991; 35:599.
  115. Geisinger KR, Wang HH, Ducatman BS, Teot LA. Gastrointestinal cytology. Chin Lab Med. 1991; 11(2):403-441.
  116. Teot LA, Geisinger KR, Richter J. Barrett's esophagus: A comparative cytolgic and histologic study of atypia, dysplasia and adenocarcinoma. Lab Invest. 1990; 62:99A.
  117. Dufour DR, Teot L. Laboratory identification of ischemic hepatitis (shock liver). 1988.
  118. Dufour DR, Teot L. Laboratory identification of ischemic hepatitis (shock liver). 1988.
  119. Parham DM, Qualman SJ, Teot L, Barr FG, Morotti R, Sorensen PH, Triche TJ, Meyer WH. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Am J Surg Pathol. 2007 Jun; 31(6):895-901.
  120. Tfayli HM, Teot LA, Indyk JA, Witchel SF. Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature. Thyroid. 2010 Sep; 20(9):1029-32.
  121. Huh WW, Anderson JR, Rodeberg D, Teot L, Yock T, Raney RB. Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2010 Jul 1; 54(7):1045-7.
  122. Pluchinotta FR, Teot LA, Sanders SP. Left ventricular aneurysm, aortic stenosis, and arcade mitral valve: coexistence of three rare congenital heart defects. Pediatr Cardiol. 2012 Oct; 33(7):1206-9.
  123. Qualman S, Lynch J, Bridge J, Parham D, Teot L, Meyer W, Pappo A. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2008 Dec 1; 113(11):3242-7.
  124. Monaco SE, Nikiforova MN, Cieply K, Teot LA, Khalbuss WE, Dacic S. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Hum Pathol. 2010 Jan; 41(1):94-102.
  125. Haygood TM, Teot L, Ward WG, Allen A, Monu JU. Low-grade chondrosarcoma in a 12-year-old boy. Skeletal Radiol. 1995 Aug; 24(6):466-8.
  126. Hettmer S, Teot LA, van Hummelen P, MacConaill L, Bronson RT, Dall'Osso C, Mao J, McMahon AP, Gruber PJ, Grier HE, Rodriguez-Galindo C, Fletcher CD, Wagers AJ. Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol. 2013 Sep; 231(1):44-52.
  127. Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol. 2013 Jul; 140(1):82-90.
  128. Henderson ER, Pohlmann RA, Teot LA, Gebhardt MC. Knee pain in a 9-year-old girl. Clin Orthop Relat Res. 2013 Oct; 471(10):3367-71.
  129. Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer. 2014 Apr 1; 120(7):1068-75.
  130. Hettmer S, Teot LA, Kozakewich H, Werger AM, Davies KJ, Fletcher CD, Grier HE, Rodriguez-Galindo C, Wagers AJ. Myogenic tumors in nevoid Basal cell carcinoma syndrome. J Pediatr Hematol Oncol. 2015 Mar; 37(2):147-9.
  131. Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol. 2015 Feb; 26(2):407-14.
  132. Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015 Jul 10; 33(20):2279-87.
To schedule an appointment: Call 617-355-7431

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close